Press Releases

Press Releases

May 11, 2022
Records in Ordering Healthcare Providers and Adopters, Set All-Time Record for AVISE® CTD Monthly Volume in March SAN DIEGO , May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended
May 1, 2022
SAN DIEGO , May 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a five-week awareness campaign to highlight important and impactful work being done to help those
April 25, 2022
SAN DIEGO , April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022 , after the market close on Wednesday, May 11, 2022 . Ron Rocca , Exagen’s President and Chief Executive
April 20, 2022
SAN DIEGO , April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2 Conference , which takes place May 3 rd - 4 th , 2022, in New York City at the Westin New York Grand Central
March 30, 2022
SAN DIEGO , March 30, 2022 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests have entered into an in-network agreement with Evolutions Healthcare Systems offering access to enhanced care to participating members.
March 22, 2022
SAN DIEGO , March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE ® tests will soon surpass 90 million lives as an in-network benefit for patients. Effective June 1, 2022 , AVISE test offerings become an
March 22, 2022
Six Quarterly Records: AVISE® CTD Volume, Testing Revenue, Testing Gross Margin, Testing Gross Margin Percent, Adopters, and Ordering Healthcare Providers SAN DIEGO , March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported
March 16, 2022
SAN DIEGO , March 16, 2022 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the formation of its new Scientific Advisory Board (SAB) with appointment of seven doctors and rheumatology experts.
Displaying 1 - 10 of 14